Disease Info Card

Dyskeratosis Congenita

Information about Dyskeratosis Congenita: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Dyskeratosis Congenita

Most recent studies have shown that Dyskeratosis Congenita shares some biological mechanisms with anemia, aplastic-anemia, bone-marrow-diseases, dermatologic-disorders, dyskeratosis, dystrophia-unguium, dystrophy, fanconi-anemia, keratosis, leukoplakia, leukoplakia-oral, malignant-neoplasms, nail-diseases, nails-malformed, neoplasms, pancytopenia, pigmentation-disorders, pulmonary-fibrosis, telomere-shortening, x-linked-dyskeratosis-congenita.

Among the many pathways, these few ones have gauged particular interests from scientists studying Dyskeratosis Congenita, and have been seen in publications frequently: Aging, Cell Cycle, Cell Death, Cell Division, Cell Proliferation, Cellular Senescence, Dna Repair, Dna Replication, Hypersensitivity, Localization, Pathogenesis, Pigmentation, Replicative Senescence, Ribosome Biogenesis, Rna Modification, Rna Processing, Rrna Processing, Senescence, Telomere Maintenance, Translation

Quite a number of genes have been found to play important roles in Dyskeratosis Congenita, such as CNGB1, CSF3, DCX, DKC1, FANCA, FXN, GAR1, NHP2, NOP10, PAFAH1B1, RNPC3, SF3B1, TERT, TINF2, TP53, USB1, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.